Analgesic action of loperamide, an opioid agonist, and its blocking action on voltage-dependent Ca2+ channels

Neuroscience Research

Volumn 46, Issue 4, 2003, Pages 493-497

  Hagiwara, Kunie ^a   Nakagawasai, Osamu ^b   Murata, Atsunobu ^b   Yamadera, Fumihiro ^b   Miyoshi, Ichiro ^a   Tan No, Koichi ^b   Tadano, Takeshi ^b   Yanagisawa, Teruyuki ^a   Iijima, Toshihiko ^c   Murakami, Manabu ^c  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Analgesia; Calcium channels; DRG neuron; Formalin; Loperamide; Mice

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ANALGESIC AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; FORMALDEHYDE; LOPERAMIDE; NALOXONE; NICARDIPINE; OPIATE AGONIST;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRIC POTENTIAL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD NERVE CELL; SPINAL GANGLION; STATISTICAL SIGNIFICANCE;

EID: 0038504839     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(03)00126-3     Document Type: Article

References (14)

1. Church J., Fletcher E.J., Abdel-Hamid K., Macdonald J.F. Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons. Mol. Pharmacol. 45:1994;747-757.
2. DeHaven-Hudkins D.L., Burgos L.C., Cassel J.A., Daubert J.D., DeHaven R.N., Mansson E., Nagasaka H., Yu G., Yaksh T.L. Loperamide (ADL-1294), an opioid antihyperalgesic agent with peripheral selectivity. J. Pharmacol. Exp. Ther. 289:1999;327-333.
3. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
4. 2+ channel in rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 280:1997;1184-1191.
5. Gohil K., Bell J.R., Ramachandran J., Milijanich G.P. Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium channel antagonist, SNX-230 (ω-conopeptide MVIIC). Brain Res. 653:1994;258-266.
6. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
7. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
8. 125I] ω-conotoxin in rat brain. Eur. J. Pharmacol. 146:1988;181-183.
9. Murakami M., Nakagawasai O., Fujii S., Hosono M., Hozumi S., Esashi A., Tanigichi R., Okamura T., Suzuki T., Sasano H., Yanagisawa T., Tan-No K., Tadano T., Kitamura K., Kisara K. Antinociceptive effect of cilnidipine, a novel N-type calcium channel antagonist. Brain Res. 868:2000;123-127.
10. 2+channels at the primary afferent neurons in mice. Eur. J. Pharmacol. 419:2001;175-181.
11. Niemegeers C.J.E., Lenaerts F.M., Janssen P.A.J. Loperamide, a novel type of antidiarrheal agent. Drug Res. 24:1974;1633-1653.
12. Niemegeers C.J.E., McGuire J.L., Heykants J.J.P., Janssen P.A.J. Dissociation between opiate-like and antidiarrheal activities of antidiarrheal drugs. J. Pharmacol. Exp. Ther. 210:1979;327-333.
13. Shannon H.E., Lutz E.A. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology. 42:2002;253-261.
14. Wuster M., Herz A. Opiate agonist action of antidiarrheal agents in vitro and in vivo: finding in support for selective action. Naunyn-Schmiedebergs Arch. Pharmacol. 1978;187-194.